Latest news
Showing 24/35 results
AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic
Mon 6 Jun 2022
AstraZeneca
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19
Mon 23 May 2022
AstraZeneca
AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts
Tue 3 May 2022
AstraZeneca
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
Mon 21 Mar 2022
AstraZeneca
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
Mon 28 Feb 2022
AstraZeneca
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Sun 2 Jan 2022
AstraZeneca
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Wed 24 Nov 2021
AstraZeneca
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval
Tue 16 Nov 2021
AstraZeneca
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
Mon 1 Nov 2021
AstraZeneca
Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis
Sun 10 Oct 2021
AstraZeneca
AZD7442 request for Emergency Use Authorization for COVID-19 prophylaxis filed in US
Tue 5 Oct 2021
AstraZeneca
AstraZeneca to fully acquire Caelum Biosciences
Thu 30 Sep 2021
AstraZeneca
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
Mon 27 Sep 2021
AstraZeneca
AstraZeneca to invest $360m in advanced manufacturing facility in Ireland
Mon 27 Sep 2021
AstraZeneca
International Respiratory Coalition launches to transform post-pandemic respiratory healthcare
Mon 13 Sep 2021
AstraZeneca
AstraZeneca lung and breast cancer data at WCLC and ESMO 2021 underscore ambition to revolutionise outcomes for patients
Fri 3 Sep 2021
AstraZeneca
AstraZeneca Appoints Dr. Susan Galbraith as Executive Vice President, Oncology Research & Development
Wed 7 Jul 2021
AstraZeneca
AstraZeneca and IDT Biologika sign letter of intent to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity
Mon 15 Feb 2021
AstraZeneca
COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials
Mon 8 Feb 2021
AstraZeneca
COVID-19 Vaccine AstraZeneca authorised for use in the EU
Mon 1 Feb 2021
AstraZeneca
AstraZeneca to showcase transformative data across diverse pipeline at World Conference on Lung Cancer
Mon 18 Jan 2021
AstraZeneca
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
Mon 4 Jan 2021
AstraZeneca
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
Mon 14 Dec 2020
AstraZeneca
AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined
Mon 26 Oct 2020
AstraZeneca